Login

Exploring the Future of Finance with Hanwha Life CEO | Kim Dong Kwan - CEO of Hanwha Corp 00:10:00

Share On Facebook Share On Twitter

Kim Dong Kwan is the CEO of Hanwha Corp

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
PECVD 200™ & FEL 200™: High-Performance Plasma CVD System | Emmanuel Lakios, President and CEO of CVD Equipment Corp
00:10:00
MindSense Data Portal: Real-Time Mining Data Visualization for Optimization
00:10:00
Ciena CEO Gary Smith discusses the acquisition of Cyan.
00:10:00
Navigating Volatility: Insights on Asset Market Dynamics Amid Rising Geopolitical Tensions | Darius Dale – Founder, 42 Macro
00:10:00
Sandstorm Gold President and CEO Nolan Watson discusses company updates, while Remark Holdings, Inc. (NASDAQ: MARK) shares market insights.
00:10:00
Ares Management's Strategic Global Expansion | Michael Arougheti, CEO , Ares Management.
00:10:00
NextView Ventures: Supporting The Dreamers|Stephanie Palmeri,Partner,NextView Ventures
00:00:00
Therapeutic Innovation - Steven A. McCarroll, Ph.D. Dorothy and Milton Flier Professor of Biomedical Science and Genetics, HMS
00:10:00
Invests in early-stage B2B and B2C tech startups with strong teams and scalable solutions|Zachariah George,Managing Partner,Launch Africa
00:10:00
Culture Rooted in Social Capital Drives Long-Term Success
00:10:00
Investing for retirement made easier | Ron Peyton,CEO and executive chairman, CIT Callan International Equity Fund
00:00:00
Gascoyne's (ASX:GCY) Mumbakine Project Will Be Acquired by Capricorn Metals (ASX:CMM) | KIM MASSEY , CHIEF EXECUTIVE OFFICER, CAPRICORN METALS LTD

© 2017 - Neuhu+